The National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC) is the largest BRC outside the South East of England and the beating heart of translational research across Greater Manchester, Lancashire and South Cumbria, transforming scientific breakthroughs into diagnostic tests and life-saving treatments for patients.
Awarded £64.1 million (2022-28) – the largest single research award given by the NIHR to the city region – Manchester BRC brings together world-leading researchers based at The University of Manchester and six of the country’s foremost NHS Trusts, with a vision to drive health improvements and lasting change for all through creative, inclusive and proactive research that identifies and bridges gaps between new discoveries and individualised care.
Manchester BRC is driving forward pioneering research in the areas of cancer (prevention and early detection, advanced radiotherapy, precision medicine, living with and beyond cancer), inflammation (rheumatic and musculoskeletal disease, respiratory medicine, dermatology, integrative cardiovascular medicine), under-researched conditions (hearing health, mental health, rare conditions) and advanced diagnostics and therapeutics (next generation phenotyping and diagnostics, next generation therapeutics).
Improving health across the city regionManchester BRC researchers have been awarded funding in the National Eczema Society’s first ever research grant round to explore how sunlight and other environmental factors can affect people with eczema.
Cells taken from the lungs of people with chronic obstructive pulmonary disease (COPD) have a larger accumulation of soot-like carbon deposits compared to cells taken from people who smoke but do not have COPD, according to a study funded by NIHR Manchester BRC.
There are plently of opportunities for people to help shape our research plans. Research is vital to help us understand more about a particular disease or condition and how to treat them.
Read more